Friday, December 5, 2025
Search

Walker & Dunlop And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Walker & Dunlop  And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Walker & Dunlop (WD), Peapack-Gladstone Financial Corporation (PGC), TrueBlue (TBI) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Walker & Dunlop (WD)

29% sales growth and 21.01% return on equity

Walker & Dunlop, Inc., through its subsidiaries, provides a range of multifamily and other commercial real estate financing products for owners and developers of real estate in the United States.

Walker & Dunlop's sales growth this year is expected to be 9.7% and 5.6% for next year.

Year-on-year quarterly revenue growth grew by 15.5%, now sitting on 1.1B for the twelve trailing months.

Volume

Today's last reported volume for Walker & Dunlop is 19564 which is 83.03% below its average volume of 115306.

Walker & Dunlop's sales growth is a negative 0% for the current quarter and 29% for the next. The company's growth estimates for the present quarter and the next is 5.1% and 30.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.01%.

Volatility

Walker & Dunlop's last day, last week, and last month's current volatility was 1.19%, 1.33%, and 1.08%, respectively.

Walker & Dunlop's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.73% (day), 2.05% (last week), and 2.36% (last month), respectively.

Walker & Dunlop's Stock Yearly Top and Bottom Value

Walker & Dunlop's stock is valued at $100.26 at 01:22 EST, way below its 52-week high of $114.77 and way above its 52-week low of $47.04.

Walker & Dunlop's Moving Average

Walker & Dunlop's value is below its 50-day moving average of $100.95 and below its 200-day moving average of $103.06.

2. Peapack-Gladstone Financial Corporation (PGC)

15% sales growth and 8.44% return on equity

Peapack-Gladstone Financial Corporation operates as the bank holding company for Peapack-Gladstone Bank that provides private banking and wealth management services in the United States.

Peapack-Gladstone Financial Corporation's sales growth this year is anticipated to be 9% and 5.9% for next year.

Year-on-year quarterly revenue growth grew by 27.1%, now sitting on 190.56M for the twelve trailing months.

Volume

Today's last reported volume for Peapack-Gladstone Financial Corporation is 88511 which is 76.07% above its average volume of 50269.

Peapack-Gladstone Financial Corporation's sales growth for the next quarter is 15%. The company's growth estimates for the current quarter and the next is 1.4% and 50%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.44%.

Volatility

Peapack-Gladstone Financial Corporation's last day, last week, and last month's current volatility was 1.69%, 0.87%, and 0.96%, respectively.

Peapack-Gladstone Financial Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.97% (day), 2.01% (last week), and 2.53% (last month), respectively.

Peapack-Gladstone Financial Corporation's Stock Yearly Top and Bottom Value

Peapack-Gladstone Financial Corporation's stock is valued at $33.74 at 01:22 EST, below its 52-week high of $33.99 and way above its 52-week low of $14.38.

Peapack-Gladstone Financial Corporation's Moving Average

Peapack-Gladstone Financial Corporation's worth is above its 50-day moving average of $31.63 and higher than its 200-day moving average of $31.20.

3. TrueBlue (TBI)

12.2% sales growth and 3.61% return on equity

TrueBlue's sales growth this year is expected to be 15.2% and 8% for next year.

Year-on-year quarterly revenue growth declined by 7.2%, now sitting on 1.81B for the twelve trailing months.

Volume

Today's last reported volume for TrueBlue is 162500 which is 2.44% above its average volume of 158620.

TrueBlue's sales growth for the next quarter is 12.2%. The company's growth estimates for the ongoing quarter and the next is 145.8% and 21.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.61%.

Volatility

TrueBlue's last day, last week, and last month's current volatility was 1.34%, 0.81%, and 1.20%, respectively.

TrueBlue's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.83% (day), 2.15% (last week), and 2.43% (last month), respectively.

TrueBlue's Stock Yearly Top and Bottom Value

TrueBlue's stock is valued at $27.48 at 01:22 EST, below its 52-week high of $29.99 and way above its 52-week low of $14.99.

TrueBlue's Moving Average

TrueBlue's worth is higher than its 50-day moving average of $26.31 and higher than its 200-day moving average of $25.07.

4. Luxfer Holdings PLC (LXFR)

11.8% sales growth and 16.32% return on equity

Luxfer Holdings PLC, a materials technology company, designs, manufactures, and supplies high-performance materials, components, and high-pressure gas cylinders for transportation, defense and emergency response, healthcare, and general industrial end-market applications.

Luxfer Holdings PLC's sales growth this year is anticipated to be 13.2% and 6.7% for next year.

Year-on-year quarterly revenue growth grew by 29.2%, now sitting on 344M for the twelve trailing months.

Volume

Today's last reported volume for Luxfer Holdings PLC is 81016 which is 2.64% below its average volume of 83217.

Luxfer Holdings PLC's sales growth for the next quarter is 11.8%. The company's growth estimates for the current quarter and the next is a negative 0% and negative -3.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.32%.

Volatility

Luxfer Holdings PLC's last day, last week, and last month's current volatility was 1.85%, 1.38%, and 1.44%, respectively.

Luxfer Holdings PLC's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.62% (day), 4.34% (last week), and 3.38% (last month), respectively.

Luxfer Holdings PLC's Stock Yearly Top and Bottom Value

Luxfer Holdings PLC's stock is valued at $20.97 at 01:22 EST, way under its 52-week high of $23.91 and way above its 52-week low of $11.74.

Luxfer Holdings PLC's Moving Average

Luxfer Holdings PLC's worth is above its 50-day moving average of $20.71 and below its 200-day moving average of $20.97.

5. Pro-Dex (PDEX)

10.3% sales growth and 32.7% return on equity

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide.

Pro-Dex's sales growth this year is expected to be 12% and 7.7% for next year.

Year-on-year quarterly revenue growth grew by 38%, now sitting on 39.72M for the twelve trailing months.

Volume

Today's last reported volume for Pro-Dex is 7210 which is 52.64% below its average volume of 15226.

Pro-Dex's sales growth for the next quarter is 10.3%. The company's growth estimates for the ongoing quarter and the next is a negative 54.7% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.7%.

Volatility

Pro-Dex's last day, last week, and last month's current volatility was 0.67%, 2.07%, and 1.51%, respectively.

Pro-Dex's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.23% (day), 4.77% (last week), and 3.27% (last month), respectively.

Pro-Dex's Stock Yearly Top and Bottom Value

Pro-Dex's stock is valued at $31.51 at 01:22 EST, way under its 52-week high of $42.60 and way above its 52-week low of $20.99.

Pro-Dex's Moving Average

Pro-Dex's worth is higher than its 50-day moving average of $30.01 and above its 200-day moving average of $28.97.

6. Sykes Enterprises (SYKE)

7.1% sales growth and 7.67% return on equity

Sykes Enterprises, Incorporated, together with its subsidiaries, provides customer experience management, multichannel demand generation, and digital transformation services.

Sykes Enterprises's sales growth this year is anticipated to be 8.3% and 4.6% for next year.

Year-on-year quarterly revenue growth grew by 11.4%, now sitting on 1.76B for the twelve trailing months.

Volume

Today's last reported volume for Sykes Enterprises is 363514 which is 25.42% below its average volume of 487455.

Sykes Enterprises's sales growth is a negative 0% for the current quarter and 7.1% for the next. The company's growth estimates for the present quarter and the next is a negative 18.3% and 7.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.67%.

Volatility

Sykes Enterprises's last day, last week, and last month's current volatility was 0.07%, 0.05%, and 0.09%, respectively.

Sykes Enterprises's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.04% (day), 0.14% (last week), and 0.32% (last month), respectively.

Sykes Enterprises's Stock Yearly Top and Bottom Value

Sykes Enterprises's stock is valued at $53.98 at 01:22 EST, below its 52-week high of $54.01 and way above its 52-week low of $30.73.

Sykes Enterprises's Moving Average

Sykes Enterprises's worth is above its 50-day moving average of $53.63 and way higher than its 200-day moving average of $46.59.

Previous days news about Sykes Enterprises(SYKE)

  • According to Business Insider on Wednesday, 25 August, "Option Care Health Inc. (OPCH) will replace Trustmark Corp. (TRMK) in the S&P MidCap 400, and Trustmark will replace Sykes Enterprises Inc. (SYKE) in the S&P SmallCap 600."